Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

ERI patents treatments for insulin resistance in diabetes accompanying obesity

31.03.2004


Dr. Miles Brennan of the Eleanor Roosevelt Institute at the University of Denver (ERI) and Dr. Ute Hochgeschwender of the Oklahoma Medical Research Foundation have patented a method of reducing insulin resistance that could lead to potential treatments for diabetes accompanying obesity.



Insulin is a hormone that prompts cells to store glucose, a natural sugar, while another hormone called glucagon has the opposite effect, prompting cells to release stored glucose into the bloodstream. In healthy individuals the two hormones achieve homeostasis, or balance. Type II diabetes occurs when the body becomes resistant to insulin, preventing it from storing glucose. Because melanocyte-stimulating hormone (MSH) causes the pancreas to secrete glucagon, MSH must be present for type II diabetes to develop. Obesity and high cholesterol are risk factors for the disease, which leads to high blood pressure, strokes, heart attacks, blindness, kidney failure and possible amputation of the lower extremities.

The new process, which is described in U.S. Patent #6,689,938, is for treatment of diabetes by administering an antagonist of MSH. The patent covers the use of a whole class of MSH antagonists, chemicals that either remove the hormone from the system or which block the action of MSH in the bloodstream.


"Because type II diabetes is essentially an insensitivity to insulin action, we can now circumvent this resistance by working on the glucagon half of the circuit," explains Brennan. "If you’re insensitive to insulin, this approach may be able to bring you back into homeostasis by decreasing glucagon in the bloodstream."

Previous treatments for type II diabetes have focused on altering the amount of glucose in the bloodstream. Brennan and Hochgeschwender instead focused on regulating insulin resistance in genetically engineered mice by manipulating the amount of MSH in the bloodstream.

"It’s a whole new way of looking at diabetes," says Brennan. "People have been working on diabetes for years, and this is an entirely unexpected departure, both in understanding how diabetes works and also in treating it."

The patent also includes a method for identifying compounds useful for reducing insulin resistance in a patient with obesity or type II diabetes. That process works by administering a peptide compound with MSH to genetically engineered mice with a modified POMC gene, which is responsible for manufacturing MSH.

Administering different MSH compounds to mice with different modifications to the POMC gene stimulates the secretion of various other hormones, which can be further studied for their roles in insulin resistance. Another patent issued to the same inventors covers mice with a range of genetic modifications to the POMC gene. The genetic modifications create obese mice that, surprisingly, do not develop diabetes.


Denver’s Eleanor Roosevelt Institute (ERI) was founded in 1961 as a private, independent research center. ERI merged with the University of Denver in 2003. The Institute is staffed by leading scientists from around the world who study Down syndrome, Lou Gehrig’s disease, cancer, obesity, type II diabetes and other diseases and conditions. It is the mission of the Institute’s scientists to seek an in-depth understanding of the process of life and through this understanding, work towards unlocking the mysteries of human health and disease.

Warren Smith | EurekAlert!
Further information:
http://www.du.edu/

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>